Artia Global Partners LP raised its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 422.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 824,363 shares of the company’s stock after acquiring an additional 666,600 shares during the […]
Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $16.00 to $15.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts also recently weighed in on ROIV. Truist Financial reissued a buy rating and […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 […]
Bank of America initiated coverage on shares of Roivant Sciences (NASDAQ:ROIV – Get Rating) in a research note published on Thursday, The Fly reports. The brokerage issued a neutral rating and a $10.50 price target on the stock. Several other equities research analysts have also recently weighed in on ROIV. HC Wainwright upped their price […]
Investment analysts at Bank of America initiated coverage on shares of Roivant Sciences (NASDAQ:ROIV – Get Rating) in a research report issued on Thursday, The Fly reports. The brokerage set a “neutral” rating and a $10.50 price target on the stock. Bank of America‘s target price points to a potential upside of 4.69% from the […]